Медицинская литература. Новинки

 

 

 

 

 

 

СОВРЕМЕННЫЕ МЕТОДЫ ОПРЕДЕЛЕНИЯ АНТИТЕЛ К РЕЦЕПТОРУ ТТГ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ БОЛЕЗНИ ГРЕЙВСА

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Фадеев В.В., Абрамова Н.А., Прокофьев С.А. и др. Антитела
к рецептору ТТГ в дифференциальной диагностике токсического зоба. Пробл. эндокринол. 2005; 51 (4): 10–18.
2. Adams D.D., Purves H.D. Abnormal responses in the assay of thyrotropin. Proc. Univ. Otago Med. Sch. 1956; 34: 11–12.
3. Ambesi)Impiombato F.S., Parks L., Coon H.G. Culture of hormone
dependent epithelial cells from rat thyroids. Proc. Natl. Acad. Sci
USA. 1980; 77: 3455–3459.
4. Costagliola S., Morgenthaler N.G., Hoermann R. et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves’ disease. J. Clin. Endocrinol. Metab.
1999; 84: 90–97.
5. De Groot L., Abalovich M., Alexander E.K. et al. Management of
thyroid dysfunction during pregnancy and postpartum: an
Endocrine Society clinical practice guideline. J. Clin. Endocrinol.
Metab. 2012; 97 (8): 2543–2565.
6. Eckstein A.K., Plicht M., Lax H. et al. Clinical results of antiinflammatory therapy in Graves' ophthalmopathy and association
with thyroidal autoantibodies. Clin. Endocrinol. (Oxf.). 2004; 61
(5): 612–618.
7. Kamijo K., Murayama H., Uzu T. et al. A novel bioreporter assay for
thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves’ disease from
painless thyroiditis than conventional thyrotropinstimulating antibody assay using porcine thyroid cells. Thyroid. 2010; 20: 851–856.
8. Kaneko T., Zor U., Field J.B. Stimulation of thyroid adenyl cyclase
activity and cyclic adenosine 3959monophosphate by long-acting
thyroid stimulator. Metabolism. 1970; 19: 430–438.
9. Kasagi K., Konishi J., Arai K. et al. A sensitive and practical assay
for thyroidstimulating antibodies using crude immunoglobulin
fractions precipitated with polyethylene glycol. J. Clin. Endocrinol. Metab. 1986; 62: 855–862.
10. Lee J., Jang H., Kim S. et al. Diagnostic value of a chimeric TSH
receptor (Mc4)based bioassay for Graves’ disease. Korean J.
Intern. Med. 2011; 26: 179–186.
11. Leschik J.J., Diana T., Olivo P.D. et al. Analytical performance and
clinical utility of a bioassay for thyroidstimulating immunoglobulins. Am. J. Clin. Pathol. 2013; 139 (2): 192–200.
12. Lytton S.D., Ponto K.A., Kanitz M. et al. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity
and severity of Graves’ orbitopathy. J. Clin. Endocrinol. Metab.
2012; 95: 2123–2131.
13. Manley S.W., Bourke J.R., Hawker R.W. The thyrotrophin receptor in guineapig thyroid homogenate: Interaction with the longacting thyroid stimulator. J. Endocrinol. 1974; 61: 437–445.
14. Meek J.C., Jones A.E., Lewis U.J., Vanderlaan W.P. Characterization of the longacting thyroid stimulator of Graves’ disease.
Proc. Natl. Acad. Sci USA. 1964; 52: 342–349.
15. Michelangeli V., Poon C., Taft J. et al. The prognostic value of thyrotropin receptor antibody measurement in the early stages of
treatment of Graves' disease with antithyroid drugs. Thyroid. 1998;
8: 119–124.
16. Nagayama Y., Wadsworth H.L., Russo D. et al. Binding domains of
stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSHlutropin/chorionic
gonadotropin receptors. J. Clin. Invest. 1991; 88: 336–340.
17. Onaya T., Kotani K., Yamada T., Ochi Y. New in vitro tests to
detect the thyroid stimulator in sera from hyperthyroid patients by
measuring colloid droplet formation and cyclic AMP in human
thyroid slices. J. Clin. Endocrinol. Metab. 1973; 36: 859–866.
18. Orgiazzi J. AntiTSH receptor antibodies in clinical practice.
Endocrinol. Metab. Clin. N. Am. 2000; 29: 339.
19. Orgiazzi J., Williams D.E., Chopra I.J., Solomon D.H. Human thyroid adenyl cyclasestimulating activity in immunoglobulin G of
patients with Graves’ disease. J. Clin. Endocrinol. Metab. 1976;
42: 341–354.
20. Pastan I., Roth J., Macchia V. Binding of hormone to tissue: the
first step in polypeptide hormone action. Proc. Natl. Acad. Sci
USA. 1966; 56: 1802–1809.
21. Pedersen I.B., Handberg A., Knudsen N. et al. Assays for thyroidstimulating hormone receptor antibodies employing different ligands and ligand partners may have similar sensitivity and specificity but are not interchangeable. Thyroid 2010; 20 (2): 127–133.
22. Pedersen I.B., Knudsen N., Perrild H. et al. TSHreceptor antibody
measurement for differentiation of hyperthyroidism into Graves'
disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin. Endocrinol. (Oxf.). 2001; 55 (3): 381–390.
23. Saravanan P., Dayan C.M. Thyroid autoantibodies. J. Clin.
Endocrinol. Metab. 2001; 30 (2): 315–337.
24. Schott M., Hermsen D., Broecker)Preuss M. et al. Clinical value of
the first automated TSH receptor autoantibody assay for the diagnosis of Graves’ disease: an international multicentre trial. Clin.
Endocrinol. (Oxf.). 2008; 71: 566–573.
25. Schott M., Morgenthaler N.G., Fritzen R. et al. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm. Metab. Res. 2004; 36 (2):
92–96.
26. Smith Rees B., Hall R. Measurement of thyrotropin receptor antibodies. Methods Enzymol. 1981; 74: 405–421.
27. Smith Rees B., Hall R. Thyroidstimulating immunoglobulins in
Graves’ disease. Lancet 1974; 2: 427–431.
28. Tamaki H., Amino N., Kimura M. et al. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan.
J. Clin. Endocrinol. Metab. 1990; 71: 1382.
29. Tozzoli R., Bagnasco M., Giavarina D., Bizzaro N. TSH receptor
autoantibody immunoassay in patients with Graves' disease:
improvement of diagnostic accuracy over different generations
of methods. Systematic review and metaanalysis. Autoimmun.
Rev. 2012; 12 (2): 107–113.
30. Vitti P., Elisei R., Tonacchera M. et al. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with
cloned human thyrotropin receptor. J. Clin. Endocrinol. Metab.
1993; 76: 499–503.
31. Watson P.F., Ajjan R.A., Phipps J. et al. A new chemiluminescent
assay for the rapid detection of thyroid stimulating antibodies
in Graves’ disease. Clin. Endocrinol. 1998; 49: 577–581.
32. Zoephel K., Gruening T., Roggenbuck D. et al. On specificity of 2nd
generation TSH receptor autoantibody measurements. Clin. Lab.
2008; 54: 243–249.

Thyrotropin receptor antibodies assays in the management of Graves' disease

Keywords: